CONMED Corporation
CNMD
$50.41
$0.591.18%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 8.34% | -15.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.34% | -15.05% | |||
| Cost of Revenue | 4.14% | -32.12% | |||
| Gross Profit | 11.40% | 4.00% | |||
| SG&A Expenses | 3.81% | -0.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.45% | -18.12% | |||
| Operating Income | 49.51% | 24.25% | |||
| Income Before Tax | 70.78% | -37.25% | |||
| Income Tax Expenses | 82.81% | -63.82% | |||
| Earnings from Continuing Operations | 66.84% | -17.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 66.84% | -17.39% | |||
| EBIT | 49.51% | 24.25% | |||
| EBITDA | 32.14% | 17.34% | |||
| EPS Basic | 69.72% | -16.36% | |||
| Normalized Basic EPS | 73.15% | 39.12% | |||
| EPS Diluted | 70.51% | -16.74% | |||
| Normalized Diluted EPS | 73.03% | 39.28% | |||
| Average Basic Shares Outstanding | -1.70% | -1.23% | |||
| Average Diluted Shares Outstanding | -1.65% | -1.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||